Obesity Drug
- All
- News
- Videos
-
8 Tips To Increase GLP-1 Hormone Levels Naturally
Glucagon-like peptide-1 (GLP-1) is a hormone secreted after eating to stimulate insulin release and suppress glucagon, a hormone that raises blood sugar, helping to lower blood sugar.
-
Weight-Loss Drugs Set To Get Cheaper In India As Semaglutide Patents Expire
The cost of popular weight-loss injections like Ozempic and Wegovy is expected to fall in India as patents on semaglutide expire in March 2026, paving the way for generic versions and wider access to anti-obesity medications.
-
Ozempic Revolution In India? Semaglutide Patent Expiry Sparks Generic Rush: Report
As the patent for semaglutide, the active ingredient in Ozempic, nears expiry, Indian pharmaceutical companies are preparing to launch cheaper generic versions.
-
Weight-Loss Surgery May Protect Your Heart More Than Drugs Like Ozempic, Mounjaro: Study
A new study suggests bariatric surgery may offer stronger long-term heart protection than GLP-1 drugs like Ozempic and Mounjaro.
-
Aishwarya Mohanraj Says She Used Mounjaro For 22 Kg Weight Loss: Doctor Explains How It Works And Who Should Avoid It
Mounjaro, a diabetes and weight-loss drug, is the brand name for tirzepatide. It is a prescription drug primarily used for type-2 diabetes. The drug is also widely used for its weight loss benefits.
-
Novo Nordisk Sues Telehealth Company Over 'Knock-Off' Weight Loss Drugs, Flags Patient Safety Risks
The lawsuit, filed in the US, alleges that Hims infringed Novo Nordisk's patent by mass marketing compounded semaglutide products that have not been cleared by the US Food and Drug Administration (FDA).
-
Can Diabetes And Obesity Drugs Help Treat Psychiatric Disorders?
A recent study highlights a surprising potential benefit of diabetes and obesity drugs, GLP-1 receptor agonists, in improving overall health and possibly extending survival in people with serious psychiatric disorders.
-
3 Weight-Loss Myths Debunked By An Obesity Expert
According to the obesity expert, many people chase the wrong number while trying to lose weight
-
6 In 10 Indians Suffering From Obesity-Related Problems: New Survey Says GLP-1 Drugs To Play Role In Treatment
GLP-1 drugs mimic the GLP-1 hormone in the body, which helps to treat type 2 diabetes and obesity. In India, GLP-1 RAs are available under various names; Ozempic, Wegovy and Mounjaro.
-
Ensure Weight Loss Drugs Are Safe, Legal Before Use In 2026: UK Health Agency
New Year is the time for many people to pledge reforms in habits and lifestyle, something resorting to drastic measures, but UK's Medicines and Healthcare products Regulatory Agency (MHRA) has urged the people to make sure an
-
8 Tips To Increase GLP-1 Hormone Levels Naturally
Glucagon-like peptide-1 (GLP-1) is a hormone secreted after eating to stimulate insulin release and suppress glucagon, a hormone that raises blood sugar, helping to lower blood sugar.
-
Weight-Loss Drugs Set To Get Cheaper In India As Semaglutide Patents Expire
The cost of popular weight-loss injections like Ozempic and Wegovy is expected to fall in India as patents on semaglutide expire in March 2026, paving the way for generic versions and wider access to anti-obesity medications.
-
Ozempic Revolution In India? Semaglutide Patent Expiry Sparks Generic Rush: Report
As the patent for semaglutide, the active ingredient in Ozempic, nears expiry, Indian pharmaceutical companies are preparing to launch cheaper generic versions.
-
Weight-Loss Surgery May Protect Your Heart More Than Drugs Like Ozempic, Mounjaro: Study
A new study suggests bariatric surgery may offer stronger long-term heart protection than GLP-1 drugs like Ozempic and Mounjaro.
-
Aishwarya Mohanraj Says She Used Mounjaro For 22 Kg Weight Loss: Doctor Explains How It Works And Who Should Avoid It
Mounjaro, a diabetes and weight-loss drug, is the brand name for tirzepatide. It is a prescription drug primarily used for type-2 diabetes. The drug is also widely used for its weight loss benefits.
-
Novo Nordisk Sues Telehealth Company Over 'Knock-Off' Weight Loss Drugs, Flags Patient Safety Risks
The lawsuit, filed in the US, alleges that Hims infringed Novo Nordisk's patent by mass marketing compounded semaglutide products that have not been cleared by the US Food and Drug Administration (FDA).
-
Can Diabetes And Obesity Drugs Help Treat Psychiatric Disorders?
A recent study highlights a surprising potential benefit of diabetes and obesity drugs, GLP-1 receptor agonists, in improving overall health and possibly extending survival in people with serious psychiatric disorders.
-
3 Weight-Loss Myths Debunked By An Obesity Expert
According to the obesity expert, many people chase the wrong number while trying to lose weight
-
6 In 10 Indians Suffering From Obesity-Related Problems: New Survey Says GLP-1 Drugs To Play Role In Treatment
GLP-1 drugs mimic the GLP-1 hormone in the body, which helps to treat type 2 diabetes and obesity. In India, GLP-1 RAs are available under various names; Ozempic, Wegovy and Mounjaro.
-
Ensure Weight Loss Drugs Are Safe, Legal Before Use In 2026: UK Health Agency
New Year is the time for many people to pledge reforms in habits and lifestyle, something resorting to drastic measures, but UK's Medicines and Healthcare products Regulatory Agency (MHRA) has urged the people to make sure an
